The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.130.3.269

An experimental group of 32 process schizophrenics was treated with regressive ECT, while a control group of 2l patients was treated with ataraxic drugs and psychotherapy. All patients were evaluated at admission and at or after discharge, using four sources of evaluation: self-ratings, psychological tests, relatives' ratings, and ratings by referring therapists. Statistical analysis of 55 variables indicated that the two groups were essentially equivalent at admission but showed significant differences on 28 of the 55 variables after discharge. All of the variables favored the experimental group treated with regressive ECT.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.